DAVITA INC. DVA on NYSE
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0000927066
0000927066
EIN:
51-0354549
51-0354549
LEI:
(CF Office: 08 Industrial Applications and Services)
Business address:
2000 16TH STREET, DENVER, CO, 80202
Phone: 310-536-2668
2000 16TH STREET, DENVER, CO, 80202
Phone: 310-536-2668
Mailing address:
2000 16TH STREET, DENVER, CO, 80202
2000 16TH STREET, DENVER, CO, 80202
Category:
Large accelerated filer
Large accelerated filer
Former names:
- DAVITA HEALTHCARE PARTNERS INC. - filings through 2016-08-12
- DAVITA INC - filings through 2012-11-02
- TOTAL RENAL CARE HOLDINGS INC - filings through 2000-01-28
Filings:
3,172 EDGAR filings since May 15, 1996
3,172 EDGAR filings since May 15, 1996
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- February 13, 2025 - SCHEDULE 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 13, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- February 13, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- November 27, 2024 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- November 18, 2024 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- February 13, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- February 13, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- October 29, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 6, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 2, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- April 26, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- March 18, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 18, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 18, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- February 13, 2025 - SCHEDULE 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- August 8, 2024 - SC 13D/A: General statement of acquisition of beneficial ownership - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 48 of 1,003 entries
Data source:
CIK0000927066.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
